Parkinson’s disease clinical research in 7MM focuses on disease-modifying agents
While Parkinson’s disease (PD) has a large and highly generalised therapeutic market, key opinion leaders (KOLs) interviewed by GlobalData have…
While Parkinson’s disease (PD) has a large and highly generalised therapeutic market, key opinion leaders (KOLs) interviewed by GlobalData have…
The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of…
In the Canadian province of Nunavut, geographic remoteness, harsh climate and historic disadvantages have exacerbated public health inequities for its…
The first week of November is National Fertility Awareness Week in the UK. According to leading data and analytics company…
At IDWeek 2024 [the annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America,…
On 23 October 2024, the Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly’s anti-amyloid beta (Aβ) monoclonal antibody…
During IDWeek 2024 in Los Angeles, California, US, case studies highlighted the current methods for detecting and preventing nontuberculous mycobacteria…
On October 21, Novo Nordisk announced positive news on the cardiovascular benefits of its oral glucagon-like peptide-1 receptor (GLP-1R) agonist,…
Over the past few days at the 128th Annual Meeting of the American Academy of Ophthalmology (AAO) 2024 in Chicago,…
On 20 October, during the American Academy of Ophthalmology (AAO) conference in Chicago, US, Hani El Helwe, MD, research fellow…